Blockchain Registration Transaction Record

Co-Diagnostics Expands South Asian Reach, Targets $13B Market

Co-Diagnostics' joint venture expands into Bangladesh, Pakistan, Nepal & Sri Lanka, targeting a $13B market for its PCR Pro point-of-care platform & SARAGENE diagnostics.

This expansion matters because it represents a strategic move to bring advanced, rapid molecular diagnostics to populous regions in South Asia with significant unmet healthcare needs. By targeting a combined market worth an estimated $13 billion, Co-Diagnostics is not just pursuing growth but potentially improving public health outcomes. The planned deployment of point-of-care platforms like CoSara PCR Pro could enable faster, more accessible testing for infectious diseases in areas where lab infrastructure may be limited. For the global diagnostics market, this signals increasing competition and innovation in emerging economies, which could drive down costs and improve technology adoption worldwide. For investors, it highlights a company executing an aggressive international growth strategy in a high-demand sector.